HAQIMONO a Non-interventional National Multicenter Study, Observing RA Patients Treated With Tocilizumab in Mono-therapy, i.e. Without Combination With DMARD
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2015
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms HAQIMONO
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 14 Oct 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 12 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.